In December 2019 a pandemic of acute respiratory distress syndromes occurs in Wuhan, china, the early evidence suggests this may be due to exposure to local sea foods in china. The pathogen was isolated from Chinese patients and designated as severe acute respiratory syndrome corona virus 2 (SARS-COV-2). COVID-19 mainly affects lungs by producing respiratory predominant symptoms like fever, cough, flu and dyspnea. As SARS-Cov-2 firstly find a mechanism to escape the immune system of humans and animals followed by a huge release of cytokines named as cytokine storms and the hyper activation of the other immune system responses. To avoid these conditions in any type of viral infections such as in SARS-Cov-2 infections and influenza virus induce lung injury vitamin D is now is recently considered as proposed therapy. Vitamin C acts as strong antioxidant and help to scavenge all the damaged species that is why vitamin C is regarded helpful in SARS-Cov-2 and other viral infections. Many findings from different clinical studies show that vitamin C when administrated orally can reduce SAR-Cov-2 and other viral infection. Taking vitamin C intravenously has also profound effect on the reduction of viral infections. As health care workers and professional are risk community for COVID-19 so vitamin C should be included in prevention and treatment of COVID-19 in this community. As vitamin C is also a prooxidant so smaller pharmacological concentration of vitamin C milli-molar is beneficial. But in case of COVID-19 high intravenous dose of vitamin C would be the right choice.
CITATION STYLE
Jan, H. (2020). COVID-19: A brief overview on the role of Vitamins specifically Vitamin C as immune modulators and in prevention and treatment of SARS-Cov-2 infections. Biomedical Journal of Scientific & Technical Research, 28(3). https://doi.org/10.26717/bjstr.2020.28.004648
Mendeley helps you to discover research relevant for your work.